Avantor is a leading global provider of integrated, tailored solutions for the life sciences and advanced technology industries. Strengthened by the recent acquisition of VWR, the Company is a trusted partner to customers and suppliers from discovery to delivery. With operations in more than 30 countries and a diverse portfolio that includes more than four million products, Avantor enables customer success through innovation, cGMP manufacturing and comprehensive service offerings. Collectively, we set science in motion to create a better world.

Website: www.avantorsciences.com.

Visit their website here https://www.genscript.com/

GenScript Biotech Corporation is a global biotechnology group. GenScript’s businesses encompass four major categories based on its leading gene synthesis technology, including operation as a Life Science CRO, enzyme and synthetic biology products, biologics development and manufacturing, as well as cell therapy.

Founded in 2002 and listed on the Hong Kong Stock Exchange in 2015, GenScript has an established global presence across Greater China, North America, the EU, and Asia Pacific. Today, over 300,000 customers from over 160 countries and regions around the world have used GenScript’s premier, convenient, and reliable products and services.

GenScript currently has more than 3000 employees globally, 33% of whom hold master’s and/or Ph.D. degrees. In addition, GenScript has a number of leading commercial technologies developed in the fields of synthetic biology, immunotherapy, antibody design, chemical synthesis and bioinformatics, including more than 70 patents and over 200 patent applications. As of January 2019, GenScript's products and services have been cited by 36,500 scientific papers worldwide.

GenScript is committed to striving towards its vision of being the most reliable biotech company in the world to make humans and nature healthier through biotechnology.

FUJIFILM has been actively pursuing reinforcement of business in the fields of bio-medical and healthcare. By leveraging FUJIFILM Group’s collective bio-related technologies, including FUJIFILM Wako Pure Chemical and FUJIFILM Irvine Scientific, FUJIFILM continues to accelerate the growth and provide broad product portfolio in bio-medical through synergies and collaborations.

FUJIFILM Wako Pure Chemical (FFWK) is a world leading supplier of high purity chemicals and reagents based in Japan. FFWK has broad product lines, from various raw materials to QC/QA testing products, in its Laboratory chemicals to precisely meet various needs in all fields of study. FFWK also maintains cell culture media production facility which follows cGMP principle, and under class 100-100,000 management with humidity/temperature control.

With over 45 years of industry experience, FUJIFILM Irvine Scientific (FISI) is a worldwide leader in the innovation and manufacture of cell culture media. FISI offers a diverse portfolio of advanced cell culture media solutions including high-performance, proprietary chemically-defined media, rapid media screening and optimization services, and close technical support designed to shorten development timelines and reduce costs. FISI adheres to both ISO and FDA regulations and currently operates dual cGMP manufacturing facilities in California, USA and Tokyo, Japan, with a third site due to be commissioned in 2021 in Tilburg, Netherlands.

http://ffwk.fujifilm.co.jp/en/index.html

http://www.irvinesci.com/

Our business is influenced by the growth in demand for biologic drugs, particularly the global market for monoclonal antibodies (mAbs). Demand for our products is associated with the overall volume of mAbs manufactured; there is little connection to final drug pricing or the clinical or commercial success or failure of an individual biologic drug.

As the number of biologic drugs on the market and in development continues to increase, and as worldwide access to biologics expands with the emergence of biosimilar and bio-better versions of original drugs, biopharmaceutical manufacturers are tasked with reducing the time and cost associated with production while improving yield and retaining the highest levels of product quality.

These market dynamics are driving process intensification and adoption of disposable technologies and other products that offer convenience, flexibility and the ability to improve capacity utilization in the most modern continuous processing facilities as well as in standard batch processing facilities. The bioprocessing products manufactured by Repligen are designed to address these important needs of biopharmaceutical manufacturers in an increasingly competitive environment.

Website: https://www.repligen.com

Pall Biotech can provide fully integrated bioprocessing solutions for gene therapy, from discovery through to commercialization; from upstream through to final filling; from initial design through to implementation.

With a range of solutions covering multiple virus types, and with production in either adherent or suspension processes, our extensive single-use portfolio can offer you the complete solution you need.

https://biotech.pall.com/

Cygnus Technologies is the leading provider of assays and services for the detection and characterization of impurities, such as host cell proteins, in biopharmaceuticals. Building on innovative, proprietary technology, the company develops highly specialized analytical products that meet the unique needs of the pharmaceutical, vaccine, gene therapy, and biotechnology industries.

Impurity analysis is an important step in biotherapeutic regulatory approval and quality control processes. With kits, immunoassay reagents, orthogonal analysis services, and expert advice, Cygnus Technologies helps biopharmaceutical companies accelerate the movement of new therapeutics through the development and approval stages to market.

Cygnus Technologies also offers outsourcing capabilities, using highly specialized technologies to develop custom, target-specific antibodies and assays. A privately held company, Cygnus Technologies was acquired by Maravai LifeSciences in 2016.

Beckman Coulter develops, manufactures and markets product that simplify, automate and innovate complex biomedical testing. Scientist use our life science research instrument to study complex biologic problems including causes of disease and potential new therapies or drugs.

Our life science customers include pharmaceutical and biotechnology companies, universities, medical schools and research institutions. Beckman Coulter has an installed base of more than 275,000 clinical and research systems operating in laboratories around the world. Beckman Coulter Korea Ltd. is responsible for sales, service & technical support of All Beckman Coulter Products including Centrifuge, Flow Cytometry, Automation and Particle Characterization and Counting System in Korea.

Website: https://www.beckmancoulter.com

USP is an independent non-profit organization that collaborates with the world’s top health and science experts to develop high-quality standards that set the bar for manufacturing and distributing safe and effective medicines, supplements and food around the globe. Two billion people world-wide have access to quality medicines, dietary supplements and food as a result of USP’s standards, advocacy and education.

At USP Biologics our primary objective is to keep you at the vanguard of standards that promote the quality of biological medicines. We do this through our rigorous and proven scientific process. And we place the outcome of our process – the physical standard as well as the method or supporting information– into your hands.

We provide a trusted, independent, single source of reliable standards that are available and used globally. Building upon our successes with more traditional biologics including Insulin and Heparin, we engage with thousands of experts, professionals, associations, regulatory agencies, and companies to pave the way for higher standards for the new wave of biologics and biosimilar drugs. It’s logical really: by actively working with the scientific community and making our rigorously researched standards available to the world, we enable you to provide access to quality medicines for all. Through a collaborative process and commitment to quality, our USP’s biologic standards help by delivering key tools and resources to help make critical medicines, such as the insulin family of products, more accessible to the global population.

To assist you in achieving high standards in drug validation and regulatory compliance as well as avoiding potentially costly mistakes, choose our globally renowned scientific approach that has provided trustworthy standards for decades. Logical really. Our process is as robust as the results you will achieve.

So why not talk with us and find out how we can help advance your biologics and biosimilars project with reliable standards?

Website: http://www.usp.org/biologics

Novasep

Novasep is a global provider of cost-effective and sustainable manufacturing solutions for life sciences molecules and fine chemicals. From the earliest steps of discovery and development to industrial scale, we provide a complementary range of purification GMP equipment and services. Modular or customized, our chromatography equipment fit perfectly with your process. As a drug substance producer and also equipment supplier, Novasep knows challenges facing pharmaceuticals and biopharmaceuticals manufacturing: time to market, cutting cost of goods (CoG), product quality, automation... Thanks to these dual competences, we have integrated these requirements when developing chromatographic products to achieve effective manufacturing processes.

Young Sciences, Inc.
Young Sciences has been recognized as a reliable company by customers with the best quality and services, and will grow together with customers. Young Sciences specializes in providing products for pharmaceutical customers, Young Sciences does not only supply bioreactor, chromatography system, sterilizers, Filling system, continuous centrifuges and isolators but also supply various kind of reagents & consumables for R&D, QC and production and CRO services. Moreover, by producing plastic labware and microbiologically-prepared plates, Young Sciences aims at contributing to the development of the bio-industry in and out of Korea. We always do our best to make customers satisfied with our support.

"Bio-Medical Science Co., Ltd.(BMS) - WE DELIVER SCIENCE

Total Solution Provider for Bio-Medical Research SINCE 1988

BMS Korea's core business started as supplying life science research and diagnostics products, and currently have expanded into clinical market as well."

ForteBio Profile

ForteBio is a business unit of Molecular Devices LLC based in Fremont, CA. We offer solutions for biomolecular analysis, including real-time analysis of biomolecular interactions (protein quantification and characterization of protein-protein interactions, etc.) in micro-volume sample sizes, providing information on affinity, kinetics, and concentration.  Our products include instrumentation, software, biosensors, and supporting services.  Our customers perform crucial work in life sciences research across academic, government and industrial settings, including pharmaceutical research, development and manufacturing.

At ILC Dover, we are focused on containing your process to get your product to market faster, safer, and cleanly. We took our ability to protect the life of an astronaut in space and applied that to protect your product and the people who make it. ILC Dover supports Pharmaceutical and Biopharmaceutical customers with disposable systems engineered to contain powder transfers from cGMP to nanogram levels. With over 300,000 successful installations world-wide since 1997. One of the critical elements of our line of products is the regulatory friendly, slip agent-free, ArmorFlex® material. These films are custom formulated to deliver superior elongation performance (nearly 500%) for ruggedness and high strength. This feature, coupled with a unique blend of safe and effective anti-static additives allows all of our products to deliver reliable high-level containment.

The ZETA Group designs, builds, automates and qualifies plants for aseptic liquid production processes in the biotech and pharmaceutical industries.
The engineering portfolio ranges from concept design for pilot plant and basic engineering, all the way through to detail engineering, installation and commissioning. The interdisciplinary project team, composed of biotech experts, process, mechanical and automation engineers, develop fast-track-projects globally. Process characterization, scaling of processes and process design are the key competences of ZETA – from lab to industrial scale.
Close to the customer ZETA provides innovative solutions along the production process of high value APIs. ZETA workflows are based on long-term experience as well as on scientific approach. Magnetic mixing technology and process-controlled freeze & thaw systems for optimal agent storage and transport complete the ZETA product portfolio.
With its nine subsidiaries in Europe and a highly qualified staff of some 500 people ZETA is global supplier in the industry. Best-in-class consultancy by ZETA moves projects towards success.

Our business is influenced by the growth in demand for biologic drugs, particularly the global market for monoclonal antibodies (mAbs). Demand for our products is associated with the overall volume of mAbs manufactured; there is little connection to final drug pricing or the clinical or commercial success or failure of an individual biologic drug.

As the number of biologic drugs on the market and in development continues to increase, and as worldwide access to biologics expands with the emergence of biosimilar and bio-better versions of original drugs, biopharmaceutical manufacturers are tasked with reducing the time and cost associated with production while improving yield and retaining the highest levels of product quality.

These market dynamics are driving process intensification and adoption of disposable technologies and other products that offer convenience, flexibility and the ability to improve capacity utilization in the most modern continuous processing facilities as well as in standard batch processing facilities. The bioprocessing products manufactured by Repligen are designed to address these important needs of biopharmaceutical manufacturers in an increasingly competitive environment.

Website: https://www.repligen.com

With Our Technology, You Can See the Future Differently
As part of the Danaher family of global life science and technology innovators, SCIEX has led the field of mass spectrometry for more than 50 years. From the moment we launched the first ever commercially successful triple quad in 1981, we have continued to develop groundbreaking technologies and solutions that have influenced life-changing research and clinical diagnostic outcomes.

We Innovate with Purpose, to Meet the Evolving Needs of the Laboratory
Big challenges face our world today, driving scientific research, routine testing and ultimately the needs of the lab. In partnership with our customers, we are at the forefront of anticipating these needs and are devoted to pioneering solutions to surpass them. We help you to discover answers for science and knowledge for life, which is why SCIEX is a trusted partner to thousands of scientific experts worldwide.

Prometic Bioseparations Ltd (PBL) has long been established as an expert in affinity chromatography and bioseparations, specifically the large-scale purification of proteins (native and recombinant) and the elimination of contaminants including pathogens. With 30 years experience in the development and large-scale manufacture of chromatography media, Prometic Bioseparations is an ideal partner for biopharmaceutical and plasma-derived therapeutics with a proven track record.

Website : www.prometicbioseparations.com

Vetter is a global leading contract development and manufacturing organization (CDMO), headquartered in Ravensburg, Germany, with production facilities in Germany and the United States. The company has long-term experience in supporting biotechnology and pharmaceutical customers both large and small. Vetter services range from early stage development support including clinical manufacturing, to commercial supply and numerous packaging solutions for vials, syringes and cartridges.

As a leading solution provider, Vetter appreciates its responsibility to support the needs of its customers by developing devices that contribute to increased patient safety, convenience, and compliance. Great importance is also given to social responsibility including environmental protection and sustainability.

Website: www.vetter-pharma.com

Cold Chain Platform (CCP) is an online resource providing cold chain related services for the bio-pharmaceutical, life science, and healthcare logistics industry. CCP’s vision is to be the first place people access to find cold chain and logistics information for the pharma industry, offering an effective route to expert cold chain information and business services. CCP connects global and local cold chain solution suppliers and users. CCP’s business support services help global companies enter into the Korean market and help Korean companies connect with global partners.

https://www.coldchainplatform.com/

Visit the website here https://biopharma-asia.com/

BioPharma Asia aims to keep its readers abreast of all developments in the areas of Drug Development, Drug Delivery, Manufacturing, Quality Assurance, Outsourcing and Regulatory Affairs, with only the highest quality articles, written by the most respected authors, associated with only end-user companies. This ensures that the information will always be guaranteed to remain timely, informative and above all totally unbiased.

 

Visit their website at https://www.asiaresearchnews.com/

Asia Research News connects research with the wider world. The service came about in the early 2000s when I heard from several prominent journalists that information about research in Asia was difficult to come by. Being an Asian researcher, and having worked as a journalist, the comments planted a seed that would germinate into Asia Research News.

Don't Miss Out on Biologics Manufacturing Korea 2020

Speaking Opportunities

Kashmiira Nayar
Conference Producer

Registration & Marketing

Aisyah Atiqah
Marketing Executive

Sponsorship & Exhibition

Akshay Shukla
Partner for Growth
en_USEnglish
zh_CN简体中文 ja日本語 ko_KR한국어 zh_TW繁體中文 en_USEnglish
Open chat
Come chat with us!
Hello! How can I help you?

Kindly fill in the form below to receive a copy of the Program via email.
Thank you for your interest and cooperation.

Products of Interest*
Blood & Plasma ProductsAntibody TherapeuticsCell TherapyGene TherapyProtein TherapeuticsViral VaccinesImmunotherapeuticsOther BiologicsNon-biologicsMedical DeviceNone of the above

Subscribe to our mailing list

Kindly fill in the form below to receive a copy of the Sponsorship Prospectus via email.
Thank you for your interest and cooperation.

Products of Interest*
Blood & Plasma ProductsAntibody TherapeuticsCell TherapyGene TherapyProtein TherapeuticsViral VaccinesImmunotherapeuticsOther BiologicsNon-biologicsMedical DeviceNone of the above

Subscribe to our mailing list

 

How effectively can I interact with the presenters?

With our event app, you can easily set up questions which the presenters are able to quickly access, in real time. Each presenter is allocated a 15-minute Q&A session, as well. In addition to this, you can also set-up meetings, exchange personal messages, and even create closed discussion groups with the speakers!

How do participants engage in networking activities?

The event app allows interaction with anyone attending through Virtual Meetups at your own convenient time. Additionally, all speakers will be present to network before and after their sessions to answer questions and interact with the exhibitors. Live Panel discussions and roundtables have been put in places to increase engagement throughout the event. The app also allows more ways to engage before, during and after the conference through live polls, custom discussion topic and 1-1 meetings which you can schedule. Kindly view the Virtual Conference guide for more details!

Will attendance at virtual conferences be greatly impacted?

To ensure participation, we are maintaining the same level of quality of content and discussions for our participants. IMAPAC is putting together a lineup of 40+ speakers, similar to the physical conference.

Which platform will I access the webinar on?

The webinar link will be embedded on our event app, ensuring networking and learning is taken care of through one platform. The app can be accessed either on your desktop or your phone.